Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

191209-f-kq373-1096

Seattle Genetics and Astellas unveil positive results for Padcev-Keytruda treatment for bladder cancer

February 12, 2020 Research and Development Astellas, Cancer, Seattle Genentics, bladder, bladder cancer, keytruda, monotherapy

Seattle Genetics and Astellas reported positive results from their trials of Padcev plus Keytruda in treating bladder cancer. The data …
News
drug_testing_2019

Chinese company starts mass producing Gilead coronavirus drug

February 12, 2020 Research and Development Ebola, Wuhan, Wuhan Coronavirus, china coronavirus

A drugmaker in China said it has started mass producing Gilead Sciences Ebola drug that has the potential to fight …
News
andrea_pfeifer_edit

Working Life Interview: Dr Andrea Pfeifer, Co-Founder and CEO, AC Immune

February 11, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AC Immune, Interview, Working Life, feature, pharma

What originally set you off on your career path? Was the plan always to go into the pharma and biotech …
Feature
1740294_bertil-lindmark-webbnyhet

Galecto hires new Chief Medical Officer

February 7, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Galecto

Galecto has announced Bertil Lindmark as their new Chief Medical Officer. He began his posting on 1 February 2020.Lindmark joins …
Appointment
rob_van_maanen

New Chief Medical Officer joins Khondrion

February 7, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Khondrion has revealed that Dr Rob van Maanen has joined the company as its new Chief Medical Officer (CMO). Dr …
Appointment
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

February 7, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MERS, Sars, china coronavirus, coronavirus, coronavirus China, wuhan coronaviurs

The Wuhan coronavirus continues to dominate the news, with China admitting its handling of the crisis had shortcomings while Gilead …
News
shutterstock_349943306

85% of patients see benefit in clinical trials, but 43% were never given the option to participate, report finds

February 7, 2020 Medical Communications, Research and Development clinical trials, pharma

Patients regularly find value in participating in clinical trials, but many are not given the option by medical professionals and …
News
abbvie_0

AbbVie’s Rinvoq hits target in psoriatic arthritis sub-population at Phase 3

February 6, 2020 Research and Development AbbVie, Rinvoq, pharma, psoriatic arthritis

AbbVie has unveiled new Phase 3 data on its selective and reversible JAK inhibitor Rinvoq (upadacitinib) in the treatment of …
News

How AI is making clinical trials more accurate and affordable

February 5, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, AI Clinical Trials, Apple, Apple Watch., apple watch, clinical trials

Clinical trials are one of the longest and most expensive steps of bringing a drug to market. Conor Kavanagh investigates …
Feature

NICE plans to use broader range of data in guidance

February 5, 2020 Research and Development NHS, NHS NICE, NICE

The British National Institute for Care Excellence has said it plans to use a broader range of data and analytics …
News

Bayer’s Eylea shows strong vision benefits across two regimens in post-marketing study

February 5, 2020 Research and Development Bayer, Eylea, pharma

Bayer has pulled back the curtain on new Phase 4 data for Eylea (aflibercept), revealing strong findings in the treatment …
News
white-passenger-plane-on-airport-during-daytime

Final UK flight from Wuhan to bring home Britons from coronavirus epicenter

February 5, 2020 Research and Development Wuhan Coronavirus, Wuhan Virus, china coronavirus, coronavirus

The last flight from Wuhan will arrive back in the UK on Sunday, bringing back British nationals fleeing from the …
News
holly_springs_9frontflags

Seqirus’ Audenz becomes first FDA-approved cell-based adjuvant influenza A vaccine

February 5, 2020 Research and Development, Sales and Marketing FDA, influenza, pharma, seqirus

The FDA has just approved the first adjuvanted, cell-based vaccine for the prevention of influenza A (H5N1) in the US, …
News
assorted-condoms

Funding cuts and government inaction has led to soaring STI rates in Britain, new study finds

February 5, 2020 Research and Development AIDS, HIV, STDs, STIs, UK, sexual health

The UK faces a new Sexually Transmitted Infection (STI) diagnoses every 70 seconds, according to a new report that outlines …
News

Insider Interview: Reducing the risk of adverse cardiovascular events

February 3, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Insider Interview, cardiovascular, heart disease, pharma

Rodrigo Gribble, Vice President Cardiovascular at AstraZeneca, breaks down recently published data from the PEGASUS trial of ticagrelor, a potential …
Feature
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026